FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine race

Malaysia News News

FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine race
Malaysia Latest News,Malaysia Headlines
  • 📰 chicagotribune
  • ⏱ Reading Time:
  • 59 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 91%

A federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.

A federal advisory committee Tuesday will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax, an early beneficiary of the government’s Operation Warp Speed program.

In clinical trials, the Novavax vaccine was found to have an efficacy of 90.4% at preventing mild, moderate or severe infection with older variants of the virus. None of the volunteers who got the vaccine experienced moderate or severe infection, translating to an efficacy of 100%. “These events raise the concern for a causal association with this vaccine,” the FDA documents stated.

The Novavax vaccine has been authorized in dozens of countries, including India, South Africa and Britain, and has also received clearance from the European Union and World Health Organization.But the vaccine is falling far short of initial hopes, both in terms of the number of vaccines distributed around the world and the number of people who are receiving them. In February 2021, Novavax pledged 1.1 billion doses to COVAX, the U.N. program supplying shots to developing countries.

As part of its initial support for Novavax’s research, the United States agreed to buy 110 million doses of the vaccine if it won authorization. But two years later, with the country already flush with effective mRNA vaccines, the government has little need for more.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

chicagotribune /  🏆 8. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyNovavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
Read more »

Novavax hoping its COVID-19 vaccine using traditional technology wins over vaccine skepticsNovavax hoping its COVID-19 vaccine using traditional technology wins over vaccine skepticsThe Novavax COVID-19 vaccine is made with an old school technology, but will it be enough to win over vaccine skeptics?
Read more »

Latest U.S. Covid-19 Surge Moves West as Pressure Eases in NortheastLatest U.S. Covid-19 Surge Moves West as Pressure Eases in NortheastThirteen California counties now have high Covid-19 community levels as the latest U.S. wave shifts westward. There are also signs of easing pressure in the Northeast.
Read more »

Trained dogs sniff out COVID-19 as well as lab tests doTrained dogs sniff out COVID-19 as well as lab tests doAnd the canines are even better than PCR tests at identifying infected people with no symptoms. COVID19 pcrtest dogs COVIDTesting pandemic Science
Read more »

Trained dogs sniff out COVID-19 as well as lab tests doTrained dogs sniff out COVID-19 as well as lab tests doDogs can be trained to sniff out COVID-19 cases. They’re overall as reliable as PCR tests and even better at IDing asymptomatic cases, a study suggests.
Read more »

Orange County man to plead guilty to $5-million COVID-19 relief loan scamOrange County man to plead guilty to $5-million COVID-19 relief loan scamRaghavender Reddy Budamala reportedly used the loans to purchase a $1.2 million 'investment property' in Eagle Rock, a nearly $600,000 property in Malibu and a 'personal residence' in Irvine.
Read more »



Render Time: 2025-02-25 14:31:46